Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
Achard
J M
JM
Leborgne
L
L
Tribouilloy
C
C
Aldigier
J C
JC
Fournier
A
A
D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005838:Genotype; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D000077583:Quinapril; D044005:Tetrahydroisoquinolines
D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril